These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20191867)

  • 21. Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure.
    Lavie CJ; Alpert MA; Arena R; Mehra MR; Milani RV; Ventura HO
    JACC Heart Fail; 2013 Apr; 1(2):93-102. PubMed ID: 24621833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of central and general adiposity to abnormal left ventricular diastolic function in a community sample with a high prevalence of obesity.
    Libhaber CD; Norton GR; Majane OH; Libhaber E; Essop MR; Brooksbank R; Maseko M; Woodiwiss AJ
    Am J Cardiol; 2009 Dec; 104(11):1527-33. PubMed ID: 19932787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity, abdominal obesity, and clustering of cardiovascular risk factors in South Korea.
    Park HS; Yun YS; Park JY; Kim YS; Choi JM
    Asia Pac J Clin Nutr; 2003; 12(4):411-8. PubMed ID: 14672864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation between obesity and the attainment of optimal blood pressure and lipid targets in high vascular risk outpatients.
    Bhan V; Yan RT; Leiter LA; Fitchett DH; Langer A; Lonn E; Tan M; Silagy S; Goodman SG; Yan AT;
    Am J Cardiol; 2010 Nov; 106(9):1270-6. PubMed ID: 21029823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of cardiovascular risk in overweight and obese people in England.
    de Lusignan S; Hague N; van Vlymen J; Dhoul N; Chan T; Thana L; Kumarapeli P
    Eur J Gen Pract; 2006; 12(1):19-29. PubMed ID: 16945868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.
    Klein S; Burke LE; Bray GA; Blair S; Allison DB; Pi-Sunyer X; Hong Y; Eckel RH;
    Circulation; 2004 Nov; 110(18):2952-67. PubMed ID: 15509809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of obesity on cardiovascular disease.
    Zalesin KC; Franklin BA; Miller WM; Peterson ED; McCullough PA
    Endocrinol Metab Clin North Am; 2008 Sep; 37(3):663-84, ix. PubMed ID: 18775358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of the myocardial performance index in a population with high prevalences of obesity, diabetes, and hypertension: the strong heart study.
    Mishra RK; Kizer JR; Palmieri V; Roman MJ; Galloway JM; Fabsitz RR; Lee ET; Best LG; Devereux RB
    Echocardiography; 2007 Apr; 24(4):340-7. PubMed ID: 17381641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of obesity and its association with cardiovascular disease risk factors in adolescent girls from a college in central Taiwan.
    Lu JJ; Jiang DD; Chou SM; Hor CB; Lay JD; Wang HL
    Kaohsiung J Med Sci; 2008 Mar; 24(3):144-51. PubMed ID: 18364275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between educational status and cardiovascular risk factors in an overweight and obese Turkish female population.
    Tanyolaç S; Sertkaya Cikim A; Doğan Azezli A; Orhan Y
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):336-41. PubMed ID: 18849223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obesity and suppressed B-type natriuretic peptide levels in heart failure.
    Mehra MR; Uber PA; Park MH; Scott RL; Ventura HO; Harris BC; Frohlich ED
    J Am Coll Cardiol; 2004 May; 43(9):1590-5. PubMed ID: 15120816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss.
    Poirier P; Giles TD; Bray GA; Hong Y; Stern JS; Pi-Sunyer FX; Eckel RH
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):968-76. PubMed ID: 16627822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes.
    Haffner SM
    Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():121S-127S. PubMed ID: 16931493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Obesity--the risk factor of cardiovascular disease in patients with chronic kidney disease?].
    Lizicárová D; Hirnerová E; Krahulec B
    Vnitr Lek; 2010 Oct; 56(10):1088-92. PubMed ID: 21105458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of obesity on the risk of heart failure and its prognosis.
    Artham SM; Lavie CJ; Patel HM; Ventura HO
    J Cardiometab Syndr; 2008; 3(3):155-61. PubMed ID: 18983332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
    Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Obesity and hypertension].
    Verdecchia P; Trimarco B
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):54S-59S. PubMed ID: 18773751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular risk-benefit profile of sibutramine.
    Scheen AJ
    Am J Cardiovasc Drugs; 2010; 10(5):321-34. PubMed ID: 20860415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mediators of target organ damage in hypertension: focus on obesity associated factors and inflammation.
    Dawood T; Schlaich MP
    Minerva Cardioangiol; 2009 Dec; 57(6):687-704. PubMed ID: 19942842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Obstructive sleep apnea-related cardiovascular disease].
    Schulz R; Grebe M; Eisele HJ; Mayer K; Weissmann N; Seeger W
    Med Klin (Munich); 2006 Apr; 101(4):321-7. PubMed ID: 16607489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.